Log in to search using one of your social media accounts:

 

A Bit of Dark Chocolate Might Sweeten Your Vision
The observed change in vision was small, but significant. However, the study authors stressed that it's too early for ophthalmologists to recommend chocolate as medicine for the eyes. (Source: WebMD Health)
Source: WebMD Health - April 26, 2018 Category: Consumer Health News Source Type: news

UMKC lands $1.97M grant for glaucoma treatment
Researchers at the University of Missouri-Kansas City School of Medicine landed $1.937 million to develop a way to treat patients with end-stage glaucoma. The five-year grant from the National Institutes of Health will support principal investigator Karl Kador's research on ways to restore vision to patients with glaucoma and other eye disorders. Kador, an assistant professor of ophthalmology and biomedical sciences, studies disease and injuries that lead to the death of retinal ganglion cells,… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 26, 2018 Category: American Health Authors: Elise Reuter Source Type: news

Medical News Today: How to safely flush your eye
If chemicals come into contact with the eye, it is essential to flush them out immediately. In this article, we describe how to flush the eyes using clean water or a solution. We also explain what to do if an object becomes lodged in the eye. Learn how to remove irritants and prevent further damage here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 26, 2018 Category: Consumer Health News Tags: Eye Health / Blindness Source Type: news

Dark chocolate improves your eye sight
Indulging in a bar of dark chocolate was found to increase blood flow and improve vision significantly more than milk chocolate in a study published Thursday by optometrists in San Antonio, Texas. (Source: the Mail online | Health)
Source: the Mail online | Health - April 26, 2018 Category: Consumer Health News Source Type: news

Endo to Acquire Somerset Therapeutics and Business of Affiliate Wintac Limited
DUBLIN, April 26, 2018 -- (Healthcare Sales & Marketing Network) -- Endo International plc (NASDAQ: ENDP) today announced that it has reached definitive agreements to acquire Somerset Therapeutics, LLC, a New Jersey based specialty pharmaceutical company ... Biopharmaceuticals, Ophthalmology, Mergers & Acquisitions Endo International, Somerset Therapeutics, Wintac Limited (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 26, 2018 Category: Pharmaceuticals Source Type: news

Novartis Launches FocalView App, Providing Opportunity for Patients to Participate in Ophthalmology Clinical Trials from Home
Novartis announced the launch of its FocalView app, an ophthalmic digital research platform created with ResearchKit. FocalView aims to allow researchers to track disease progression by collecting real-time, self-reported data directly from consenting patients. By adapting the design of clinical trials to suit the daily routine of patients, the app may reduce barriers to participation, leading to a more nuanced understanding of ophthalmic diseases and potentially accelerating the development of novel treatments. (Source: eHealth News EU)
Source: eHealth News EU - April 26, 2018 Category: Information Technology Tags: Featured Industry Business and Industry Source Type: news

Novartis launches FocalView app, providing opportunity for patients to participate in ophthalmology clinical trials from home
FocalView is a first-of-its-kind app designed to modernize ophthalmic clinical trials, making them more accessible and flexible Using patients' self-recorded measurements, FocalView aims to enable more sensitive trial endpoints and more accurate patient... Biopharmaceuticals, Ophthalmology, Product Launch Novartis, FocalView (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 25, 2018 Category: Pharmaceuticals Source Type: news

Novartis launches FocalView app, providing opportunity for patients to participate in ophthalmology clinical trials from home
Novartis announced the launch of its FocalView app, an ophthalmic digital research platform created with ResearchKit. FocalView aims to allow researchers to track disease progression by collecting real-time, self-reported data directly from consenting patients. By adapting the design of clinical trials to suit the daily routine of patients, the app may reduce barriers to participation, leading to a more nuanced understanding of ophthalmic diseases and potentially accelerating the development of novel treatments. (Source: World Pharma News)
Source: World Pharma News - April 25, 2018 Category: Pharmaceuticals Tags: Featured Novartis Business and Industry Source Type: news

World's smallest optical implantable biodevice
(Nara Institute of Science and Technology) Researchers in Japan have built a new optical device no bigger than the edge of a coin. The device includes a photovoltaic cell that is powered by infrared light and emits blue light. Using infrared light allows the device to be implanted several centimeters deep into the body, while the emission of blue light can be used for optogenetic control of brain patterns. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 25, 2018 Category: Biology Source Type: news

Researchers develop new tools in the fight against diabetic blindness
(University of Missouri-Columbia) Estimates are that 600 million people will have some sort of diabetic retinopathy by 2040. Previously, no good animal models existed that scientists could use to study the disease, its diagnosis or potential treatments. Now, a team of researchers led by the University of Missouri has employed a mouse model exhibiting diabetic retinopathy symptoms that could lead to future translational research studies. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 25, 2018 Category: International Medicine & Public Health Source Type: news

American College of Physicians, April 19 - 21
(Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - April 25, 2018 Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Oncology, Ophthalmology, Orthopedics, ENT, Pathology Source Type: news

Aldeyra Therapeutics Announces First Patient Enrolled in Allergic Conjunctivitis Phase 3 Clinical Trial
LEXINGTON, Mass., April 24, 2018 -- (Healthcare Sales & Marketing Network) -- Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company devoted to development of next-generation medicines to improve the lives of patients with inflammato... Biopharmaceuticals, Ophthalmology Aldeyra Therapeutics, reproxalap, allergic conjunctivitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 24, 2018 Category: Pharmaceuticals Source Type: news

Medical News Today: What causes bumps on the eyeball?
Finding a bump on the eyeball can be alarming, but most causes are harmless and easily treatable. In this article, we look at issues that can cause a bump to form, including a stye and a scratched cornea. We also describe types of bumps. Here, learn about treatment, home care, and how to prevent bumps from reoccurring. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 24, 2018 Category: Consumer Health News Tags: Eye Health / Blindness Source Type: news

Report: Johnson & Johnson sees Vision Care biz grow, looks to expand beyond contacts
Johnson & Johnson (NYSE:JNJ) saw its vision care sales grow 34% last quarter over its previous first quarter as it looks to significantly grow the business into the surgical and device segments, according to a CNBC report. The company added a number of surgical products alongside a contact subscription service, which come in addition to its existing popular Acuvue contact lens line, according to the report. The investment has seen a significant return for the company, becoming one of its fastest-growing platforms. Johnson & Johnson only began investing in eye surgery two years ago after announcing it would acq...
Source: Mass Device - April 23, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Optical/Ophthalmic Wall Street Beat johnsonandjohnson Source Type: news

Blindness after facial trauma: epidemiology, incidence and risk factors: a 27-year cohort study of 5708 patients - Stathopoulos P, Igoumenakis D, Mezitis M, Rallis G.
OBJECTIVES: This was a 27-year study of a cohort of 5708 patients who had sustained maxillofacial fractures. Our purpose was to present the etiology, mechanism of trauma, site, and concomitant injuries that led to visual loss. We hypothesize that fractures... (Source: SafetyLit)
Source: SafetyLit - April 23, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Choroidal Thickness Changes in Patients With Untreated DM
MONDAY, April 23, 2018 -- The choroidal thickness changes in patients with untreated diabetes mellitus over time, according to a study published online April 14 in Clinical& Experimental Ophthalmology. Hiroaki Endo, from Teine Keijinkai... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 23, 2018 Category: Pharmaceuticals Source Type: news

Deep Learning Applications in Ophthalmology Deep Learning Applications in Ophthalmology
Find out how deep learning models could apply within the field of ophthalmology.Current Opinion in Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 23, 2018 Category: Consumer Health News Tags: Ophthalmology Journal Article Source Type: news

Glowing contact lens could prevent a leading cause of blindness
(California Institute of Technology) A glow-in-the-dark contact lens developed by graduate students working for Yu-Chong Tai, Caltech's Anna L. Rosen Professor of Electrical Engineering and Medical Engineering, could help stave off blindness in the hundreds of millions of people who suffer from diabetes across the globe. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 23, 2018 Category: International Medicine & Public Health Source Type: news

Medical News Today: Why is my eyelash growing in the wrong direction?
Instead of becoming trapped under the skin, an ingrown eyelash may grow in the wrong direction, toward the eye. This is called trichiasis, and it can cause irritation, pain, and damage to the cornea. Injury, inflammation, or certain conditions may be responsible. Medical treatment is often necessary. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 21, 2018 Category: Consumer Health News Tags: Eye Health / Blindness Source Type: news

In-Depth: How digital health is changing marathons
Forty mph winds pelted cold rain against the runners as they approached the Boston Marathon ’s infamous Heartbreak Hill. It was just before this mark that runner Courtney Duckworth’s eyesight started to blur. She couldn’t tell if her senses were warped from the terrible weather conditions or if it was something more serious. Living with Type 1 diabetes, she is used to keeping track o f her health while she runs.    (Source: mobihealthnews)
Source: mobihealthnews - April 20, 2018 Category: Information Technology Source Type: news

Dorzolamide Hydrochloride/Timolol Maleate Ophthalmic Solution (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - April 20, 2018 Category: Drugs & Pharmacology Source Type: news

Dorzolamide Hydrochloride Ophthalmic Solution (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - April 20, 2018 Category: Drugs & Pharmacology Source Type: news

UPMC notifying patients due to employee that developed TB
UPMC said Friday a UPMC Presbyterian ER employee developed tuberculosis and the system is notifying and testing patients and staff who may have come in contact with the employee. The employee of the Presby emergency department, who was not identified, is on medical leave and recovering at home. UPMC said the employee had also been a patient at a doctor’s office at Magee-Womens Hospital of UPMC and the ophthalmology clinic at Presby. Tuberculosis is an airborne disease c aused by bacteria that… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 20, 2018 Category: Biotechnology Authors: Paul J. Gough Source Type: news

UPMC notifying patients due to employee that developed TB
UPMC said Friday a UPMC Presbyterian ER employee developed tuberculosis and the system is notifying and testing patients and staff who may have come in contact with the employee. The employee of the Presby emergency department, who was not identified, is on medical leave and recovering at home. UPMC said the employee had also been a patient at a doctor’s office at Magee-Womens Hospital of UPMC and the ophthalmology clinic at Presby. Tuberculosis is an airborne disease c aused by bacteria that… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 20, 2018 Category: American Health Authors: Paul J. Gough Source Type: news

Hill-Rom Enhances Spot(TM) Vision Screener To Serve Senior Population
New software advances early detection of vision loss among patients with pupil sizes as small as 3mm CHICAGO, April 20, 2018 -- (Healthcare Sales & Marketing Network) -- Hill-Rom (NYSE: HRC) announced new enhancements to its Welch Allyn Spot™ Vision Sc... Devices, Ophthalmology, Product Launch Hill-Rom, Welch Allyn Spot, Vision Screener (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 20, 2018 Category: Pharmaceuticals Source Type: news

Medical News Today: How long are you contagious with pink eye?
Pink eye is a relatively common eye condition. There are many potential causes, but one of the most significant problems is how not to spread the condition to others. There are different types of pink eye, which can change the length of contagiousness. Knowing the signs can help a person avoid infecting anybody else. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 20, 2018 Category: Consumer Health News Tags: Eye Health / Blindness Source Type: news

Spark Therapeutics' ground-breaking gene therapy now being administered at select hospitals
Spark's first product, Luxturna, was approved by the FDA in December to treat an inherited retinal disorder that leads to blindness if untreated. The first patients have been treated with the gene therapy, which is now available at a select group of medical centers. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 20, 2018 Category: Pharmaceuticals Authors: John George Source Type: news

Healthy Diet, Healthy Eyes
Title: Healthy Diet, Healthy EyesCategory: Health NewsCreated: 4/19/2018 12:00:00 AMLast Editorial Review: 4/20/2018 12:00:00 AM (Source: MedicineNet Eyesight General)
Source: MedicineNet Eyesight General - April 20, 2018 Category: Opthalmology Source Type: news

A Boy With Suddenly Failing Vision A Boy With Suddenly Failing Vision
An otherwise healthy 5-year-old boy presents after a failed vision exam. What's causing the decline in his eyesight?Medscape Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 18, 2018 Category: Consumer Health News Tags: Ophthalmology Case Challenge Source Type: news

Medical News Today: Does the 20-20-20 rule prevent eye strain?
The 20-20-20 rule says that after spending 20 minutes on the computer, a person should spend 20 seconds looking at an object 20 feet away. This may help to prevent eyes from becoming dry or watery. Here, learn why the 20-20-20 rule is effective. We also describe other ways to protect the eyes from digital strain. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 18, 2018 Category: Consumer Health News Tags: Eye Health / Blindness Source Type: news

Giant cell arteritis breakthrough: ‘Astonishing’ new drug on NHS prevents deadly symptoms
TEMPORAL arteritis, or giant cell arteritis, is a life-threatening condition that requires urgent treatment. Steroids have been used to prevent ‘emergency’ symptoms, including strokes and blindness. But, a new “astonishing” drug - available on the NHS from today - has left one patient feeling like “a different woman”. (Source: Daily Express - Health)
Source: Daily Express - Health - April 18, 2018 Category: Consumer Health News Source Type: news

Emory gets $12.7 million to continue researching oxytocin
The National Institute of Mental Health gave Emory University's Yerkes National Primate Research Center and Brain Health Center $12.7 million to continue researching oxytocin, a chemical in the brain known for fostering mother-infant bonds.   The research team will use the five-year grant to use technology like gene editing and optogenetics in research with rodents and nonhuman primates to understand how oxytocin acts in the brain, including its role in neural communication and social functioning.… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 17, 2018 Category: Pharmaceuticals Source Type: news

Thinking about hitching a ride on a mission to Mars? One hazard you haven't considered
(American Academy of Ophthalmology) Retired NASA astronaut David Wolf, M.D., will provide insight into how space flight affects the eye on Thursday, April 19, when he gives the keynote address during a conference attended by many of the nation's leading eye physicians and surgeons, hosted by the American Academy of Ophthalmology in Washington, D.C. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 17, 2018 Category: International Medicine & Public Health Source Type: news

Recommendations Developed on Gender Equity in Medicine
ACP supports equitable physician compensation based on comparable work at each stage of career (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - April 17, 2018 Category: Respiratory Medicine Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Oncology, Ophthalmology, Orthopedics, ENT, Pathology Source Type: news

Ivantis touts 1-year head-to-head Hydrus, iStent study data
This study looks at the viability of MIGS in patients who don’t need or may have already had cataract surgery, so it’s a vital addition to our growing body of evidence supporting MIGS,” Compare trial medical monitor Dr. Iqbal Ahmed said in a prepared release. Ivantis said the 152-patient trial was the first to compare two minimally invasive glaucoma surgery device for treating open-angle glaucoma in a standalone procedure. The study aimed to compare safety and effectiveness of both devices in lowering IOP and reducing eye-drop medication. Results at one year showed that 47% of eyes treated with the Hydrus...
Source: Mass Device - April 16, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Optical/Ophthalmic Glaukos Ivantis Source Type: news

Glaukos touts 2-year iStent inject pivotal trial data, levies infringement suit against Ivantis
Glaukos (NYSE:GKOS) today released two-year data from the FDA investigational device exemption pivotal trial of its iStent inject trabecular micro-bypass system, and announced a patent infringement suit it filed against Ivantis. Results of the 505-patient study were presented at the American Society of Cataracts and Refractive Surgery annual meeting by Dr. Thomas Samuelson of the Minnesota Eye Consultants, the San Clemente, Calif.-based company said. The iStent inject trabecular micro-bypass system is designed to treat mild-to-moderate open-angle glaucoma in patients undergoing cataract surgery. It uses a pa...
Source: Mass Device - April 16, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Optical/Ophthalmic Patent Infringement Glaukos Source Type: news

Nonoptimized Drug Therapy Costs More Than $ 500 Billion Annually
After initial Rx use, average cost of individual having treatment failure, new medical problem over $ 2,000 (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - April 16, 2018 Category: Respiratory Medicine Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

Africa:Isdb Group Sets To Embark On 2nd Generation Of Its Massive Health Project To Fight Avoidable Blindness In 12 African Countries
[Islamic Solidarity Fund for Development] In preparation for the launching of 2nd Generation (phase) of the Alliance to Fight Avoidable Blindness (AFAB), the Islamic Development Bank (IsDB) and the Islamic Solidarity Fund for Development, ISFD, hosted a Coordination Meeting in the city of Istanbul on 19-20th March, 2018. The official launching of AFAB 2nd Generation is to take place on the sidelines of the 43rd Annual Meeting of the Board of Governors of the IsDB Group in Tunis, Tunisia, 1-5 April, 2018. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 16, 2018 Category: African Health Source Type: news

Opthalmological sequelae due to paintball injuries: case studies - Pe ñaranda AC, Montoya A, Arciniegas AP, López-de-Mesa C.
OBJECTIVE: Describe the ophthalmological sequelae of patients diagnosed with blunt eye injury by paintball. MATERIAL AND METHODS: There were a total 14 cases with a diagnosis of blunt trauma by paintball were treated at the ophthalmology emergency departme... (Source: SafetyLit)
Source: SafetyLit - April 16, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Fish Oil Supplements Fail to Ease Dry Eye, Study Shows
Title: Fish Oil Supplements Fail to Ease Dry Eye, Study ShowsCategory: Health NewsCreated: 4/13/2018 12:00:00 AMLast Editorial Review: 4/16/2018 12:00:00 AM (Source: MedicineNet Eyesight General)
Source: MedicineNet Eyesight General - April 16, 2018 Category: Opthalmology Source Type: news

Telemedicine Useful in Detecting Retinopathy of Prematurity Telemedicine Useful in Detecting Retinopathy of Prematurity
Telemedicine has similar accuracy to ophthalmoscopy in detecting clinically significant retinopathy of prematurity (ROP), researchers say.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 13, 2018 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

Stem-cell-based Implant Feasible in Macular Degeneration Stem-cell-based Implant Feasible in Macular Degeneration
A bioengineered implant of human embryonic stem-cell-derived retinal pigment epithelium (RPE) may be of benefit in advanced dry age-related macular degeneration (AMD), according to preliminary research.Reuters Health Information (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - April 13, 2018 Category: Transplant Surgery Tags: Ophthalmology News Source Type: news

Allergan launches TruTear tear-producing neurostim
Allergan (NYSE:AGN) said today it launched its TruTear neurostimulation device designed to temporarily increase tear production. The FDA-cleared device is designed to be inserted into the nasal cavity to induce the production of natural tears, and is the only such device of its kind, the Dublin-based company said. “TrueTear is the latest in a long line of innovations that have helped make Allergan a leading global eye care company. We are excited to add this drug-free, drop-free treatment option for adult patients with inadequate tear production to our current portfolio.  This milestone truly repr...
Source: Mass Device - April 13, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Neuromodulation/Neurostimulation Optical/Ophthalmic Allergan Source Type: news

Dry Eye: No Benefit From Fatty Acid Supplements Dry Eye: No Benefit From Fatty Acid Supplements
Omega-3 fatty acid supplementation relieved dry eye to the same extent as placebo olive oil in a randomized controlled trial.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 13, 2018 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

Fish oil: Omega-3 fatty acids 'won't save your eyesight'
POPPING a daily fish oil pill won't save your vision, say scientists. A study found omega-3 fatty acids found in sardines, salmon, mackerel were no better than a dummy tablet of olive oil at relieving dry eyes. (Source: Daily Express - Health)
Source: Daily Express - Health - April 13, 2018 Category: Consumer Health News Source Type: news

Fish Oil Supplements Fail to Ease Dry Eye, Study Shows
FRIDAY, April 13, 2018 -- There was hope that the omega-3 fatty acids found in fish oil supplements might ease the discomfort of chronic dry eye. But new research suggests that isn't so. " Contrary to a long-held belief in the ophthalmic community,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 13, 2018 Category: General Medicine Source Type: news

Low-Vision Rehab Improves Several Elements of Visual Function
FRIDAY, April 13, 2018 -- Low-vision (LV) rehabilitation is associated with improvement in several dimensions of visual function, according to a study published online April 12 in JAMA Ophthalmology. Kevin T. Stroupe, Ph.D., from the Edward Hines... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 13, 2018 Category: Pharmaceuticals Source Type: news

Health Tip: Using Glaucoma Eye Drops
-- Eye drops are a popular way to treat glaucoma, a group of diseases that, if untreated, can damage the optic nerve and lead to blindness. To be safe and effective, however, these eye drops must be used as prescribed by a doctor. The U.S. National... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 13, 2018 Category: General Medicine Source Type: news

Health Tip: Using Glaucoma Eye Drops
Title: Health Tip: Using Glaucoma Eye DropsCategory: Health NewsCreated: 4/13/2018 12:00:00 AMLast Editorial Review: 4/13/2018 12:00:00 AM (Source: MedicineNet Eyesight General)
Source: MedicineNet Eyesight General - April 13, 2018 Category: Opthalmology Source Type: news

FDA Permits Marketing of IDx-DR for Automated Detection of Diabetic Retinopathy in Primary Care
IDx-DR becomes the first autonomous, AI-based diagnostic system authorized for marketing by the FDA CORALVILLE, Iowa, April 12, 2018 -- (Healthcare Sales & Marketing Network) -- IDx, a privately-held AI diagnostics company, announced today that the U.S... Devices, Ophthalmology, FDA, Product Launch IDx, IDx-DR, Diabetic Retinopathy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 12, 2018 Category: Pharmaceuticals Source Type: news